243 Efficient generation of CD8+ TSCM CD19 chimeric antigen receptor T-cells (CAR-T cells) by treatment with novel cytokine-based scaffolds

Registros relacionados

• 295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells
  por: Scott Garforth, et al.
  Publicado em: (2023-11-01)
• Efficient derivation of chimeric-antigen receptor-modified TSCM cells
  por: Emiko Kranz, et al.
  Publicado em: (2022-07-01)
• Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system
  por: Peter S. Chang, et al.
  Publicado em: (2024-01-01)
• Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
  por: Silvia Arcangeli, et al.
  Publicado em: (2020-06-01)
• Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells
  por: Blair B. Madison, et al.
  Publicado em: (2022-09-01)